Suppr超能文献

中浆经半剂量光动力疗法治疗后脉络膜毛细血管层、Sattler 层和 Haller 层厚度的变化。

CHANGES IN CHORIOCAPILLARIS, SATTLER, AND HALLER LAYER THICKNESSES IN CENTRAL SEROUS CHORIORETINOPATHY AFTER HALF-FLUENCE PHOTODYNAMIC THERAPY.

机构信息

Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.

Clínico San Carlos University Hospital, Madrid, Spain.

出版信息

Retina. 2020 Dec;40(12):2373-2378. doi: 10.1097/IAE.0000000000002764.

Abstract

PURPOSE

To determinate the variation in thickness of the individual choroidal layers in patients with central serous chorioretinopathy treated with half-fluence photodynamic therapy.

METHODS

Twenty-two eyes were evaluated with spectral-domain optical coherence tomography. The images were taken before photodynamic therapy, 3 months, and 6 months after the treatment. Two investigators performed these measurements: 1) choroidal thickness (CT), 2) Haller layer thickness, defined as the most external layer containing a 100-μm vessel, and 3) choriocapillaris + Sattler layer (C&S). Nine measurements were taken in the macular region.

RESULTS

Choroidal thickness before photodynamic therapy was 471.8 µm ± 145.8. The Haller layer was 358.4 µm ± 122.6, and C&S was 114.3 µm ± 27.8. At 3-month follow-up, CT was 441.1 µm ± 150.7, Haller layer 348.8 µm ± 127.6, and C&S 92.4 µm ± 27.9. At 6-month follow-up, CT was 420.4 µm ± 118.4, Haller layer 331.8 µm ± 97.2, and C&S 89.5 µm ± 28.0. Using a multilevel mixed-effects linear regression, CT was found to be reduced at both 3 months (P < 0.03) and at 6 months (P < 0.001), Haller layer showed no significant reduction at 3 months (P = 0.483) or at 6 months (P = 0.055), and C&S showed reduction at 3 months (P < 0.001) and at 6 months (P < 0.001). Fellow nonaffected eyes showed no statistical variation at 3-month and 6-month follow-up.

CONCLUSION

Reduction in CT in patients affected by central serous chorioretinopathy after half-fluence photodynamic therapy occurs primarily in the choriocapillaris and medium diameter vessel layers of the choroid in a short- and medium-term follow-up.

摘要

目的

确定接受半剂量光动力疗法治疗的中心性浆液性脉络膜视网膜病变患者各脉络膜层厚度的变化。

方法

使用频域光相干断层扫描对 22 只眼进行评估。在光动力疗法前、治疗后 3 个月和 6 个月采集图像。两名研究人员进行了以下测量:1)脉络膜厚度(CT),2)Haller 层厚度,定义为含有 100μm 血管的最外层,3)脉络膜毛细血管+Sattler 层(C&S)。在黄斑区进行了 9 次测量。

结果

光动力疗法前 CT 为 471.8μm±145.8。Haller 层为 358.4μm±122.6,C&S 为 114.3μm±27.8。在 3 个月随访时,CT 为 441.1μm±150.7,Haller 层为 348.8μm±127.6,C&S 为 92.4μm±27.9。在 6 个月随访时,CT 为 420.4μm±118.4,Haller 层为 331.8μm±97.2,C&S 为 89.5μm±28.0。使用多级混合效应线性回归,发现 CT 在 3 个月(P<0.03)和 6 个月(P<0.001)时均减少,Haller 层在 3 个月(P=0.483)和 6 个月(P=0.055)时均无明显减少,C&S 在 3 个月(P<0.001)和 6 个月(P<0.001)时减少。对侧非受影响眼在 3 个月和 6 个月随访时均无统计学差异。

结论

在接受半剂量光动力疗法治疗的中心性浆液性脉络膜视网膜病变患者中,CT 在短期和中期随访中主要减少,发生在脉络膜的脉络膜毛细血管和中等直径血管层。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验